The impact of different DNA extraction kits and laboratories upon the assessment of human gut microbiota composition by 16S rRNA gene sequencing by Kennedy, Nicholas A et al.
The Impact of Different DNA Extraction Kits and
Laboratories upon the Assessment of Human Gut
Microbiota Composition by 16S rRNA Gene Sequencing
Nicholas A. Kennedy1, Alan W. Walker2, Susan H. Berry3, Sylvia H. Duncan4, Freda M. Farquarson4,
Petra Louis4, John M. Thomson5, UK IBD Genetics Consortium", Jack Satsangi1, Harry J. Flint4,
Julian Parkhill2, Charlie W. Lees1., Georgina L. Hold3*.
1Gastrointestinal Unit, Centre for Genomic and Experimental Medicine, University of Edinburgh, Western General Hospital, Edinburgh, United Kingdom, 2 Pathogen
Genomics Group, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridgeshire, United Kingdom, 3Gastrointestinal Research Group,
Division of Applied Medicine, Aberdeen University, Aberdeen, United Kingdom, 4 Rowett Institute of Nutrition and Health, Aberdeen University, Aberdeen, United
Kingdom, 5Department of Digestive Disorders, Aberdeen Royal Infirmary, Foresterhill, Aberdeen, United Kingdom
Abstract
Introduction: Determining bacterial community structure in fecal samples through DNA sequencing is an important facet of
intestinal health research. The impact of different commercially available DNA extraction kits upon bacterial community
structures has received relatively little attention. The aim of this study was to analyze bacterial communities in volunteer
and inflammatory bowel disease (IBD) patient fecal samples extracted using widely used DNA extraction kits in established
gastrointestinal research laboratories.
Methods: Fecal samples from two healthy volunteers (H3 and H4) and two relapsing IBD patients (I1 and I2) were
investigated. DNA extraction was undertaken using MoBio Powersoil and MP Biomedicals FastDNA SPIN Kit for Soil DNA
extraction kits. PCR amplification for pyrosequencing of bacterial 16S rRNA genes was performed in both laboratories on all
samples. Hierarchical clustering of sequencing data was done using the Yue and Clayton similarity coefficient.
Results: DNA extracted using the FastDNA kit and the MoBio kit gave median DNA concentrations of 475 (interquartile
range 228-561) and 22 (IQR 9-36) ng/mL respectively (p,0.0001). Hierarchical clustering of sequence data by Yue and
Clayton coefficient revealed four clusters. Samples from individuals H3 and I2 clustered by patient; however, samples from
patient I1 extracted with the MoBio kit clustered with samples from patient H4 rather than the other I1 samples. Linear
modelling on relative abundance of common bacterial families revealed significant differences between kits; samples
extracted with MoBio Powersoil showed significantly increased Bacteroidaceae, Ruminococcaceae and Porphyromonadaceae,
and lower Enterobacteriaceae, Lachnospiraceae, Clostridiaceae, and Erysipelotrichaceae (p,0.05).
Conclusion: This study demonstrates significant differences in DNA yield and bacterial DNA composition when comparing
DNA extracted from the same fecal sample with different extraction kits. This highlights the importance of ensuring that
samples in a study are prepared with the same method, and the need for caution when cross-comparing studies that use
different methods.
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Introduction
The last decade has seen a marked rise in interest in the
bacterial communities that coexist within humans, facilitated by
the availability of modern molecular techniques. The Human
Microbiome Project[1] and MetaHIT[2] have made considerable
progress in furthering our understanding of microbial diversity and
community structure in different body areas of healthy individuals.
The gastrointestinal tract is the most heavily colonized organ in
the body, with 70% of bacteria found in humans residing in the
colon[3–5]. Differences in the diversity and community structure
of the gut microbiota have been associated with diseases of the
gastrointestinal tract such as inflammatory bowel disease
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(IBD)[6,7] and irritable bowel syndrome[8], as well as metabolic
disorders like type 2 diabetes mellitus and obesity[9].
Determining the bacterial community structure in fecal samples
through amplification and sequence analysis of extracted DNA has
revolutionized gastrointestinal microbiology research over recent
years. These culture-independent techniques for assessing diversity
have largely replaced traditional culture based approaches as they
are considered to be less biased in terms of defining true diversity
and considerably less labor-intensive[10,11]. Due to the recent
rapid increase in DNA-based phylogenetics of bacterial commu-
nities many different DNA extraction procedures are used, each
with its own potential biases. All methods rely on chemical or
mechanical disruption, lysis using detergents, or a combination of
these approaches.
Previous studies have evaluated differences between DNA
extraction methods from fecal samples, exploring detection with
conventional PCR[12,13], quantitative PCR[14,15], bands on
denaturing gradient gel electrophoresis (DGGE)[15–20] and
phylogenetic microarray[21]. Significant differences in relative
abundance have been demonstrated when DNA was extracted
using different methods from mock communities of bacteria and
assessed by 16S rRNA sequencing[22,23]. Wu et al. described the
effect of different fecal extraction methods on 16S rRNA
pyrosequencing, comparing QIAamp DNA Stool Minikit, MoBio
PowerSoil DNA Isolation Kit and Stratec PSP Spin Stool DNA
Kit[24].
The aim of this study was to analyze bacterial communities in
healthy volunteer and IBD patient fecal samples extracted using
the MoBio and FastDNA DNA extraction kits in two established
gastrointestinal research laboratories. The MoBio Power Soil
DNA extraction kit and the MP Biomedicals Fast DNA Spin Kit
for Soil DNA extraction kit are two commonly used extraction
procedures for fecal microbial diversity studies[25–27]. Both
methods use a combination of mechanical disruption and chemical
lysis.
Methods
Fecal sample collection and initial processing
Fecal samples were taken from two patients with IBD (I1 and I2)
and from two healthy controls (H3 and H4) using the Fisher Fecal
Commode Collection Kit. Fecal samples were kept at 4uC and
processed within 4 hours of collection. This short period of storage
is not expected to influence molecular estimation of microbial
community composition[25]. Each sample was thoroughly mixed
and several aliquots of 500 mg were dispensed. Aliquots were
distributed between two established microbial research laborato-
ries (Institute of Medical Sciences (IMS) and The Rowett Institute
of Nutrition and Health (RINH), both Aberdeen University) and
then subject to further processing as detailed in Figure 1 and
described below.
Ethics Statement
Ethical approval was granted by North of Scotland Research
Ethics Service (03/0137 and 12/NS/0061) on behalf of all
participating centers and written informed consent was obtained
from all subjects.
MoBio PowerSoil DNA extraction procedure
One 500 mg fecal aliquot was used for MoBio PowerSoil DNA
isolation kit extraction. 5 ml of MoBio lysis buffer was immediately
added to the fresh fecal sample, which was then vortex mixed for
30–40 seconds. Fecal suspensions were then centrifuged
(1,500 g65 minutes) and 1 ml of the supernatant placed into the
MoBio Garnet bead tubes containing 750 ul of MoBio buffer.
These tubes were then heated at 65uC for 10 minutes, then at
95uC for 10 minutes. Samples were then stored at 280uC prior to
processing in both laboratories following the manufacturer’s
instructions. DNA was eluted in 100 mL MoBio elution buffer.
FastDNA SPIN Kit for Soil procedure
For each fecal sample 26500 mg aliquots were placed in
FastDNA SPIN Kit lysing matrix E tubes and 978 ml of sodium
phosphate buffer and 122 ml MT buffer were added to each tube
and vortex mixed. One aliquot was then stored at 280uC and was
defined as FastDNA method 1. The second aliquot was subjected
to additional processing by heating at 65uC for 10 minutes, then at
95uC for 10 minutes followed by storage at 280uC. This was
defined as FastDNA method 2. Both aliquots were then processed
following manufacturer’s (Qbiogene, MP Biomedicals, Illkirch,
France) instructions. DNA was eluted in 100 mL FastDNA elution
buffer.
PCR amplification
Fecal DNA was quantified by Nanodrop mass spectrophotom-
etry before dilution to 25 ng/ml. Initial PCR amplification was
undertaken at each laboratory with Invitrogen AccuPrime Taq
DNA Polymerase High Fidelity utilising a per-reaction mix of 2 ml
of DNA template, 2 ml of Buffer II, 0.2 ml (2 mM) Fusion Primer A,
0.2 ml (2 mM) Fusion Primer B, 0.08 ml (1 U) Accuprime Taq and
15.52 ml sterile, deionized water to a final volume of 20 ml.
Quadruplicate PCR reactions were set up per DNA sample. The
16S rRNA gene primers, spanning the V3-5 region of the 16S
rRNA gene, were configured as follows: 338F, 59-
CCTATCCCCTGTGTGCCTTGGCAGTCTCAGACTCCTACGG-
GAGGCAGCAG-39, where the bases in italics are 454 Lib-L kit
adaptor ‘‘B’’, and 926R, 59- CCATCT-
CATCCCTGCGTGTCTCCGACTCAG-Marker-
CCGTCAATTCMTTTRAGT-39, where the underlined bases
are 454 adaptor ‘‘A’’ and the marker sequence was a unique 12-
mer string of error-correcting Golay barcode bases for each
sample[28]. No barcode was added to the forward primer. Hence
the PCR products were flanked by a 40 bp fusion primer/
multiplex identifier sequence at the reverse end and a 30 bp fusion
primer at the forward end. PCR cycling conditions were as
follows: 2 minutes at 94uC; 20 cycles of 30 seconds at 94uC, 30
seconds at 53uC, 120 seconds at 68uC. Following confirmation of
adequate and appropriately sized product, the quadruplicate
reactions were pooled and ethanol precipitated prior to purifica-
tion as per the recommended AMPure purification method for
454 sequencing. The PCR products were then sequenced with the
Roche 454 Titanium sequencing platform using the Lib-L kit
(Wellcome Trust Sanger Institute, Cambridgeshire, UK). The
sequence data are available from the European Nucleotide
Archive under Study Accession Numbers ERP004371 and
ERP004372, and Sample Accession Numbers ERS373486 and
ERS373498. The relevant barcode information for each of the
samples is shown in Table S1.
Quantitative PCR
Quantitative real-time PCR was performed as described
previously[29]. Briefly, standard curves consisted of ten-fold
dilution series of amplified bacterial 16S rRNA genes from
reference strains. Samples were amplified with universal primers
against total bacteria and specific primers against Bacteroidaceae,
Ruminococcaceae, Lachnospiraceae, Enterobacteriaceae (Table 1). The
abundance of 16S rRNA gene copies was determined from
standard curves and specific bacterial groups were expressed as a
Extraction Kit Impact on Fecal Bacterial Diversity
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percentage of total bacteria determined by universal primers. 5 ng
of DNA was used per reaction. The same DNA concentration was
used for all runs, including universal primer runs which were used
to normalize specific bacterial groups against total bacteria, to
minimize errors due to any inhibitory substances in the samples.
The detection limit was determined with negative controls
containing only herring sperm DNA.
Bioinformatic and Statistical Analysis
Analysis of sequence data was carried out using the Mothur
software package[30]. Initially, the ‘‘trim.seqs’’ function was used
to filter reads for quality by truncating them once average quality
scores dropped below 35 across a rolling window of 50 bases. In
addition all reads with any mismatches to the primer or barcode
sequences, plus reads with ambiguous bases (i.e. ‘‘N’’s) or with
homopolymeric stretches of longer than 8 bases were removed.
Read length following this step ranged from 336 to 351 bp.
Chimeras were then checked for and removed using Perseus
software[31], as implemented in Mothur. The sequences were
then aligned to the reference SILVA database provided in
Mothur, a distance matrix generated, and then clustered into
operational taxonomic units (OTUs) at 97% similarity using the
average neighbor setting in Mothur. Each OTU was assigned a
taxonomic classification at all levels from Phylum to Genus using
Figure 1. Study protocol. IMS: Institute of Medical Sciences, University of Aberdeen, Foresterhill, Aberdeen; RI: Rowett Institute of Nutrition and
Health, University of Aberdeen, Bucksburn, Aberdeen.
doi:10.1371/journal.pone.0088982.g001
Table 1. qPCR primers used.
Bacterial family Primer name Primer sequence Reference
All bacteria UniF GTGSTGCAYGGYYGTCGTCA [38]
UniR ACGTCRTCCMCNCCTTCCTC
Bacteroidaceae Bac303F GAAGGTCCCCCACATTG
Bfr-Fmrev CGCKACTTGGCTGGTTCAG
Ruminococcaceae Clep866mF TTAACACAATAAGTWATCCACCTGG
Clept1240mR ACCTTCCTCCGTTTTGTCAAC
Lachnospiraceae Erec482F CGGTACCTGACTAAGAAGC
Erec870R AGTTTYATTCTTGCGAACG
Enterobacteriaceae EnterobactDmod2F GACCTCGCGAGAGCA [29]
Enter1432mod CCTACTTCTTTTGCAACCCA
doi:10.1371/journal.pone.0088982.t001
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the reference Ribosomal Database Project database (RDP)
provided in Mothur with the Gemmiger/Subdoligranulum classification
error corrected. Jaccard and Yue and Clayton distance matrices
were calculated using the vegan package in R[32]. Dendrograms
were generated using Ward clustering, and then visualized using
the iTOL web package[33].
Comparisons in DNA yield were performed using Mann
Whitney U testing. Linear modelling was used to assess the
relative contribution of patient, DNA extraction method and
extraction site to the measured proportions of different bacterial
families. Log-transformed data was used to permit analysis of the
fold change. A model was constructed for each bacterial family
using the donor source, extraction method and extraction site as
covariates. Bacterial families were reported where at least one
sample had an abundance of 5% or more. For each family,
samples were only included from participants with at least 0.5%
abundance for that bacterial family in one or more of their
samples. Modelling was also done in a similar manner using
individual OTUs. When using linear modelling at the OTU level,
Holm’s method was used to correct for multiple testing.
Correlation between pyrosequencing and qPCR data was done
using Pearsons’s correlation coefficient. Analysis was performed
using R 2.15.2 (R Statistical Foundation, Vienna, Austria).
Results
DNA yields were significantly higher with either method of the
FastDNA kit than with the MoBio kit, with median DNA
concentrations of 476 ng/mL (interquartile range [IQR] 290–
519) for FastDNA method 1, 453 ng/mL (IQR 228–689) for
FastDNA method 2 and 22 ng/mL (IQR 9-36) for the MoBio
method (p,0.001 for both comparisons, Figure 2). There was no
significant difference in yield between the two methods of the
FastDNA kit (p = 0.798).
Compositional analysis indicated a higher proportion of
Enterobacteriaceae and Sutterellaceae, and lower Ruminococcaceae, in
the samples from the two IBD patients compared with the two
healthy controls, regardless of the extraction method or labora-
tory. Although this study was clearly not powered to differentiate
between IBD cases and controls the higher observed proportions
of Proteobacteria in cases, particularly case I2, is consistent with
patterns described previously in IBD[6,7].
Clustering of the microbiota composition derived from the
sequence data for these samples was carried out using both the
Jaccard and the Yue and Clayton calculators. The Jaccard
calculator is used to describe overlap in community membership
between different samples and ignores the proportional abundance
of each OTU while, in contrast, the Yue and Clayton calculator
takes the proportional abundance of each OTU into account
when comparing community similarities. Jaccard-based calcula-
tions revealed a clear clustering of samples primarily by subject of
origin (Figure 3a). This is as expected given the well-known inter-
individual variation in microbiota composition between individ-
uals[34]. Within individuals, however, the MoBio-processed
samples tended to cluster together, separately to those processed
using the FastDNA kit, indicating that, although there were overall
similarities in the range of organisms that were identified using the
two DNA extraction kits, there is some bias associated with the use
of each kit. More serious repercussions of using different DNA
extraction kits were observed when using the Yue and Clayton
distance metric, where dominant organisms can have more impact
on clustering patterns. The MoBio-processed samples of subject I1
clustered with the samples from subject H4 rather than with the
FastDNA-processed samples from patient I1, presumably as a
result of elevated Bacteroides and lower Lachnospiraceae proportional
abundances in the MoBio extractions compared to the FastDNA
extractions (Figure 3b). This demonstrates that biases introduced
by DNA extraction methodology can over-ride the real underlying
patterns of community structure driven by inter-individual
variation.
Linear modelling of the family level data for the top nine
families represented in the pyrosequencing data is shown in
Table 2 (range of abundances in table S2). Significant differences
were identified between the FastDNA and MoBio kits, with
relatively higher Bacteroidaceae, Ruminococcaceae and Porphyromonada-
ceae, and lower Enterobacteriaceae, Lachnospiraceae, Clostridiaceae and
Erysipelotrichaceae following extraction with the MoBio kit. There
was a significant difference identified between the two methods of
the FastDNA kit in just one family, the Rikenellaceae. The extraction
site made a significant difference only for Sutterellaceae, with the
observed differences being driven by an increase in one OTU in
samples from patients H4 and I1 when they had been extracted at
RINH (Using FastDNA methods in patient H4, relative
abundance 0.24% (95% confidence interval 0.11-0.38%) at IMS
and 2.64% (0.85-4.44%) at RINH.) The site at which the
amplification PCR was performed made no significant difference
for any of the bacterial families analyzed, and was therefore
excluded from the models.
At the OTU level, 18 OTUs were significantly different
between the MoBio kit and the FastDNA kit after correction for
multiple testing (Table 3). Of these, 10 were from the Lachnospir-
aceae family and 8 of these 10 were relatively under-represented in
the MoBio processed samples, in some cases with a complete
absence of the OTU in the MoBio samples.
Correlation between pyrosequencing and qPCR data was
generally good (Figure 4), with R2 values of 0.81, 0.86 and 0.94
for Ruminococcaceae, Bacteroidaceae and Enterobacteriaceae respectively.
However, the correlation was less good for the Lachnospiracaeae,
with an R2 value of 0.42. Linear modelling revealed similar
differences to that seen in the pyrosequencing data, although the
differences related to extraction method were only significant for
Ruminococcaceae and Enterobacteriaceae (Tables 4, S3).
Figure 2. Comparison of DNA yields between extraction
methods.
doi:10.1371/journal.pone.0088982.g002
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Discussion
With the recognition that cultured bacteria cover only a small
proportion of gut microbial diversity[35], a number of molecular
techniques have been developed to describe and quantify the gut
microbiota, from qualitative gel-based methods to full metage-
nomic sequencing[5,36]. Almost all of these techniques require
extraction of DNA from fecal or mucosal samples as a first step,
and differences at this point will influence downstream results. The
importance of this will be amplified if, for example, cases and
controls are processed in a different manner.
This study highlights important differences in the performance
of two commercially available kits for DNA extraction from fecal
samples. Significantly lower DNA yields were seen with the MoBio
kit than the FastDNA kit. This is consistent with results published
previously[19]. More importantly, there were significant differ-
ences in the relative abundance of bacteria measured at both the
family and OTU level. There is no gold standard to which these
data can be compared, and so it is impossible to say which
technique yields results closer to the true profile of the samples.
However, the lower yield of the MoBio kit, and reduced
proportional abundance of the Lachnospiraceae family of Firmicutes,
suggests that this kit may not be stringent enough for optimal
lysing of some Gram-positive organisms. Regardless, these
differences are such that it is important to stipulate that all
samples in a particular experiment should be extracted using the
same technique. This is of particular importance with multicenter
studies. Moreover, it should prompt researchers to exercise
caution when comparing datasets from different studies. Indeed,
if DNA has been extracted using different kits then studies should
not be considered cross-comparable. Of note, a recent meta-
analysis found that samples from studies of fecal microbiota within
Western populations clustered by study, suggesting that systematic
bias was introduced by factors such as DNA extraction
technique[37].
The importance of the observed differences will depend on the
analysis techniques used. However, whenever a relative quantifi-
cation technique is used, the results for even a single organism will
be influenced by the effects of the extraction technique on the total
number of bacteria isolated relative to that specific species. The
methods for both kits used here involved physical disruption by
bead-beating. Methods that rely on enzymatic treatment without
physical disruption have been shown previously to give biased
recovery, with reduced recovery of Gram-positive organisms and
artificially elevated levels of Gram negatives, presumably because
these are more easily lysed[18,22].
A smaller effect was observed of the extraction site on relative
abundance, with only Sutterellaceae reaching statistical significance.
This may reflect a difference in operator, equipment or laboratory
environment. To minimize the influence of differences between
laboratories, centralization of DNA extraction for an experiment
would be preferred. The technique described here includes only
minimal processing after sample collection prior to interim storage
at 280uC. This allows for collection sites to collate a number of
samples in280uC storage prior to shipment to a central facility for
DNA extraction and downstream analysis.
The qPCR data in general correlated well with that from
pyrosequencing with the exception of Lachnospiracaeae. This can be
partially explained by differences between the range of organisms
that were targeted by the qPCR primers and those that were
classified as Lachnospiracaeae in the pyrosequencing data, although
78% of OTUs and 89% of sequences labelled as Lachnospiracaeae
were estimated in silico to be targeted by the qPCR primer set used.
Ariefdjohan et al. previously assessed the effect of DNA
extraction method on the measured bacterial composition of stool
using denaturing gradient gel electrophoresis (DGGE)[19]. This
study demonstrated variability in bacterial community between
fecal samples extracted with QIAamp DNA, MoBio Ultra Clean
Fecal DNA and FastDNA SPIN kits, and noted that both the
MoBio and Qiagen kits were not able to extract DNA from all the
bacteria in the specimen. More recently, Claassen et al. used
DGGE, terminal restriction fragment length polymorphism (T-
RFLP) and qPCR to compare fecal samples extracted using kits
from Qiagen, ZymoResearch and MoBio and found few
Figure 3. Dendrogram of the representation of bacterial families derived from 16S rRNA gene sequences within each sample
clustered by Jaccard (A) and Yue and Clayton (B) distances.
doi:10.1371/journal.pone.0088982.g003
Table 2. Linear modelling of family-level pyrosequencing data.
Bacterial Family Kit Extraction Site
FastDNA 2 fold
change p MoBio fold change P RINH fold change p
Patients
included
Lachnospiraceae 0.96 (0.74–1.25) 0.775 0.63 (0.49–0.81) 0.001 1.17 (0.95–1.44) 0.160 H3,H4,I1,I2
Bacteroidaceae 1.13 (0.79–1.63) 0.501 2.13 (1.49–3.05) ,0.001 1.09 (0.81–1.46) 0.561 H3,H4,I1,I2
Ruminococcaceae 0.94 (0.79–1.13) 0.524 1.32 (1.11–1.58) 0.005 0.95 (0.82–1.10) 0.516 H3,H4,I1
Enterobacteriaceae 1.08 (0.74–1.57) 0.695 0.61 (0.43–0.88) 0.016 0.85 (0.63–1.15) 0.311 I1,I2
Sutterellaceae 0.77 (0.18–3.37) 0.735 1.11 (0.26–4.69) 0.892 3.84 (1.18–12.46) 0.031 H3,H4,I1,I2
Clostridiaceae 1.00 (0.77–1.30) 0.976 0.46 (0.36–0.59) ,0.001 0.88 (0.71–1.08) 0.243 I1,I2
Porphyromonadaceae 1.46 (0.41–5.19) 0.560 4.03 (1.16–14.01) 0.035 0.70 (0.26–1.94) 0.502 H3,H4,I1,I2
Erysipelotrichaceae 1.21 (0.81–1.81) 0.361 0.32 (0.21–0.47) ,0.001 0.88 (0.64–1.22) 0.445 H3,H4,I1,I2
Rikenellaceae 0.35 (0.16–0.76) 0.016 0.72 (0.33–1.56) 0.418 0.65 (0.35–1.19) 0.181 H3,H4
RINH: Rowett Institute of Nutrition and Health.
Participants were excluded if all data points for that bacterial family were , 0.5%. Reference sample was from participant H3 using FastDNA method 1 and extracted at
the Institute of Medical Sciences. Differences are shown as fold change with 95% confidence intervals.
doi:10.1371/journal.pone.0088982.t002
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Table 3. Multiple linear modelling after correction for multiple testing shows OTUs with significantly different relative abundance
after extraction with the MoBio kit.
Genus Family Order Class Phylum Fold change p Corrected p
Patients
included
Eggerthella Coriobacteriaceae Coriobacteriales Actinobacteria Actinobacteria 0.00 (0.00–0.00) 5.0961029 5.5561027 I1
Blautia Lachnospiraceae Clostridiales Clostridia Firmicutes 0.00 (0.00–0.01) 1.7061027 1.8361025 H3,H4,I1
Blautia Lachnospiraceae Clostridiales Clostridia Firmicutes 0.01 (0.00–0.04) 2.0161027 2.1561025 H3,H4,I1
Bacteroides Bacteroidaceae Bacteroidales Bacteroidia Bacteroidetes 2.60 (1.92–3.52) 3.2661027 3.4661025 H3,H4,I1,I2
Clostridium sensu
stricto
Clostridiaceae Clostridiales Clostridia Firmicutes 0.36 (0.30–0.43) 3.9161026 0.0004 I1
Blautia Lachnospiraceae Clostridiales Clostridia Firmicutes 0.01 (0.00–0.05) 1.9761025 0.0020 H3,H4,I1
unclassified Ruminococcaceae Clostridiales Clostridia Firmicutes 0.17 (0.12–0.24) 3.1361025 0.0032 H3
unclassified Lachnospiraceae Clostridiales Clostridia Firmicutes 0.00 (0.00–0.01) 3.4961025 0.0036 H4,I1
Anaerostipes Lachnospiraceae Clostridiales Clostridia Firmicutes 0.10 (0.04–0.23) 5.2361025 0.0053 H3,H4
Escherichia
Shigella
Enterobacteriaceae Enterobacteriales Gamma-
proteobacteria
Proteobacteria 0.41 (0.28–0.59) 1.3661024 0.0136 I1,I2
unclassified Lachnospiraceae Clostridiales Clostridia Firmicutes 5.05 (2.55–9.97) 2.2461024 0.0222 H3,I1
Ruminococcus Ruminococcaceae Clostridiales Clostridia Firmicutes 0.48 (0.34–0.68) 0.0002 0.0232 H3,H4,I1
unclassified Lachnospiraceae Clostridiales Clostridia Firmicutes 2.50 (1.92–3.26) 0.0003 0.0250 H3
unclassified Ruminococcaceae Clostridiales Clostridia Firmicutes 3.19 (2.26–4.50) 0.0003 0.0298 H3
Bacteroides Bacteroidaceae Bacteroidales Bacteroidia Bacteroidetes 2.03 (1.42–2.89) 0.0004 0.0342 H3,H4,I1,I2
Dorea Lachnospiraceae Clostridiales Clostridia Firmicutes 0.00 (0.00–0.06) 0.0004 0.0343 H3,H4,I1
unclassified Lachnospiraceae Clostridiales Clostridia Firmicutes 0.00 (0.00–0.00) 0.0004 0.0358 I1
Dorea Lachnospiraceae Clostridiales Clostridia Firmicutes 0.06 (0.01–0.25) 0.0004 0.0381 H3,H4,I1,I2
Samples were excluded if all data points for that bacterial family were,0.5%. Reference sample was from patient H3 using either FastDNA method and extracted at the
Institute of Medical Sciences. Differences are shown as fold change with 95% confidence intervals.
doi:10.1371/journal.pone.0088982.t003
Figure 4. Correlation between pyrosequencing and qPCR data.
doi:10.1371/journal.pone.0088982.g004
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significant differences[20]. In contrast, the previous study by Wu et
al. which assessed the effect of extraction methods on 16S rRNA
pyrosequencing demonstrated increased yield of Firmicutes when
a hot phenol bead-beating method or the PSP kit were used. The
present study helps bring further clarity to this important issue
with next generation sequencing permitting a more detailed
exploration of the differences between samples extracted with
different methods.
This study is somewhat limited by its relatively small sample
size, with fecal samples obtained from only four individuals. There
were a small number of outliers; samples H4F2AA and H4F2AR
had much higher relative abundance of Bacteroidaceae. In addition,
the data obtained here from both pyrosequencing and qPCR
estimate relative abundance rather than absolute numbers and
focus on the dominant groups within the microbiota.
Conclusions
This study demonstrates important differences in the yield and
relative abundance of key bacterial families for kits used to isolate
bacterial DNA from stool. This highlights the importance of
ensuring that all samples to be analyzed together are prepared
with the same DNA extraction method, and the need for caution
when comparing studies that have used different methods.
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Table 4. Linear modelling of qPCR data.
Bacterial Family Kit Extraction Site
FastDNA 2 fold changep MoBio fold change P RINH fold change p Patients included
Lachnospiraceae 0.75 (0.48–1.17) 0.209 0.74 (0.48–1.16) 0.199 1.35 (0.94–1.94) 0.107 H3,H4,I1,I2
Bacteroidaceae 1.19 (0.94–1.51) 0.147 1.25 (0.99–1.57) 0.066 0.98 (0.81–1.18) 0.822 H3,H4,I1,I2
Ruminococcaceae 0.69 (0.47–1.01) 0.070 2.32 (1.58–3.39) ,0.001 1.26 (0.92–1.71) 0.157 H3,H4,I1
Enterobacteriaceae 1.28 (0.97–1.69) 0.102 0.65 (0.48–0.87) 0.011 0.91 (0.72–1.15) 0.436 I1,I2
RINH: Rowett Institute of Nutrition and Health.
Participants were excluded if all data points for that bacterial family were ,0.5%. Reference sample was from participant H3 using FastDNA method 1 and extracted at
the Institute of Medical Sciences. Differences are shown as fold change with 95% confidence intervals.
doi:10.1371/journal.pone.0088982.t004
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